Navigation Links
Mayo Clinic identifies new risk factor for heart attack patients
Date:11/5/2007

ORLANDO, Fla. -- If you go to the hospital within one to two hours of the onset of symptoms of a heart attack, your chances of getting proper treatment are nearly 70 percent greater than those who wait 11 to 12 hours before seeking treatment, according to results presented today at the American Heart Associations Scientific Sessions 2007 in Orlando, Fla.

This research should emphasize to patients that getting help immediately, by calling 911, gives them the best chance of receiving treatments we know can help save their lives or lessen the damage to their hearts, says Henry Ting, M.D., lead Mayo Clinic cardiovascular researcher on the national study. If patients wait at home for hours with symptoms and come in later, unfortunately they arent getting the proper treatments.

The most serious type of heart attack is known as an ST-elevation myocardial infarction (STEMI). In a STEMI, critical arteries supplying the heart with blood are blocked. Previous studies have shown that the best treatment for STEMI patients is reperfusion therapy -- when a patients blocked artery is opened by inflating a balloon at the site of the blockage or by delivering clot-dissolving medication, thus restoring blood flow to heart muscle.

Significance of the Mayo Clinic Research

The study is the largest and most detailed review of multiple elements in patient records contained in a national heart attack database. These elements are: time delay from onset of symptoms to hospital arrival; treatment with reperfusion; and treatment outcome. After analyzing 440,398 heart attack incidents from 1995 to 2004 in the National Registry of Myocardial Infarction, the researchers identify for the first time a novel risk factor for heart attack deaths that appears to have a readily available solution: comply with the American Heart Association/American Cardiology Association guidelines now in place. The guidelines state that if a patient has symptoms consistent with a heart attack which are not relieved after five minutes, or after placing one nitroglycerin pill under the tongue, the patient should call 911.

About the Study

The records that the team reviewed document how long it took for 440,398 heart attack patients to arrive at the hospital after their symptoms started, and correlate arrival time with the rates of reperfusion therapy they received upon arriving at the hospital.

Results show that:

  • Of patients who arrived at the hospital within one to two hours of onset of heart attack, 77 percent received reperfusion therapy.

  • Of patients who arrived at the hospital within two to three hours of onset of heart attack, 73 percent received reperfusion therapy.

  • Of patients who arrived at the hospital within 11 to 12 hours of onset of heart attack, only 46 percent of patients received reperfusion therapy.

Although current guidelines recommend that STEMI patients who reach the hospital within 12 hours after their symptoms started should receive reperfusion therapy, we found that this is not happening, Dr. Ting says. These delays represent a novel and modifiable risk factor and warrant further investigation. These results show that gaps remain in quality of care in patients with STEMI -- first, we need to encourage patients with potential heart attacks to come to the hospital as early as possible; second, hospitals need to implement systems that treat all eligible patients rapidly regardless of the delay in presentation.


'/>"/>

Contact: Traci Klein
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

Related medicine news :

1. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
2. Radiologists encouraged to look beyond cancer for clinically unseen diseases
3. Clinical depression linked to abnormal emotional brain circuits
4. Preclinical study suggests organ-transplant drug may aid in lupus fight
5. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
6. AASM encourages those student-athletes at risk for developing osa to visit a sleep clinic
7. Thailand: Partners Open Free AIDS Treatment Clinic in Renowned AIDS Temple in Lop Buri
8. MinuteClinic Becomes Participating Provider with Assurant Health
9. Therap Services Continues to Hire Experienced Developmental Disability Industry Clinicians for its Customer Support Team
10. Acupuncturists Relocation Tightens Relationship With Fertility Clinic
11. Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... Saint Francis Hospital ... years, and the efforts have paid off. Since implementation of these efforts, ... care to enhance perioperative patient experiences and reduce costly complications. Since implementation in ...
(Date:5/26/2016)... ... May 26, 2016 , ... Development Team of Pixel ... for FCPX. , "This new layered style transition tool will keep a consistent flow ... CEO of Pixel Film Studios. , TranSweep is an all new layered style ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... industry leader in Blood Pressure products . , High blood pressure affects ... effects. Left untreated, high blood pressure can lead to heart disease, stroke, kidney ...
(Date:5/25/2016)... ... May 26, 2016 , ... The United States Food and Drug Administration ... both men and women. To date, the company is the first and only manufacturer ... adult who suffers with androgenetic alopecia. , “This new level of clearance substantiates ...
(Date:5/25/2016)... ... 25, 2016 , ... The Georgia State University College of Law new building ... Design Commission. , The annual award recognizes projects, programs, individuals and organizations that have ... of its physical heritage and the balance between the old and the new. , ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... LONDON , May 24, 2016 ... erfüllt beide primären Endpunkte ... und Überlegenheit in ‚ausgezeichneter plus guter ... aufsteigenden Colons    ,      (Logo: ... B.V. gab heute neue positive Daten von der ...
(Date:5/24/2016)... -- NxStage Medical, Inc. (Nasdaq: NXTM ), a ... today announced that Jeffrey H. Burbank , Chief ... of investor conferences. Where applicable, a webcast of the ...   ... Friday, June 10, 2016 1:30 p.m. ET ...
(Date:5/24/2016)... HONG KONG , May 24, 2016 /PRNewswire/ ... primer stent de doble terapia del mundo, introduce ... fístula arteriovenosa. OrbusNeich, una compañía global ... cambian las vidas, ha expandido su cartera incluyendo ... catéteres balón JADE™ y Scoreflex™ PTA son los ...
Breaking Medicine Technology: